SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Point and Figure Charting -- Ignore unavailable to you. Want to Upgrade?

To: Judy who wrote (9906)11/19/1998 3:34:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 34802
 
[Amended] Judy, you asked me to keep you updated about IMNX. Faber reported on CNBC that Enbrel is soon to be launched and company expects great sales from this product, co. has bought back $millions (???) worth of drugs from its manufacturer (cost of drug is 1/5 of what IMNX is selling it for). Sales is said to be above analysts expectations. That's the gist of it.

P.S. It seemed our posts crossed. I agree with your comments at the pharma news thread.



To: Judy who wrote (9906)11/20/1998 2:46:00 AM
From: silInv  Respond to of 34802
 
Judy,

I took the other bad one instead of IMNX :-(

Saw your trade of IMNX and wish you more profitable
future on this one. Is it still a buy now? CNTO is coming out
a better one sometimes next year (am I right about the timing)?
Based on Anthony's report, the sales is good so it should
at least to be a good short buy.

Let me know when you see opportunity in the oil drillers
and I will keep on watching.

Thank you for your valuable feedback.

silinv


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News